Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OrthoLogic files PMA (premarket approval) supplement for spinal stimulator:

This article was originally published in Clinica

Executive Summary

OrthoLogic has filed a premarket approval (PMA) supplement with the US FDA for its SpinaLogic-1000 non-invasive device which stimulates spinal fusion. The device uses combined magnetic field technology to treat patients with spinal fusion in 30-minute daily treatments. If approved, it will be the Tempe, Arizona-based company's first entry into the spinal fusion market. The new supplement is based on the company's PMA for its OL-1000 bone growth stimulator, which received FDA approval in 1994.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083322

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel